HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$1.16

EPS Forecast

$298.2

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
RVMDRevolution Medicines IncREPLReplimune Group IncDNLIDenali Therapeutics IncIOVAIovance Biotherapeutics IncCRBUCaribou Biosciences Inc